Printer Friendly
The Free Library
14,716,498 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

American Oriental Bioengineering Institutional Coverage To Be Initiated By Investrend Research.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- (Investrend Research Syndicate) American Oriental Bioengineering bioengineering

Application of engineering principles and equipment to biology and medicine. It includes the development and fabrication of life-support systems for underwater and space exploration, devices for medical treatment (see
 Inc. (AMEX AMEX

See: American Stock Exchange
: AOB AOB (on the agenda for a meeting) any other business ) has enrolled in the unique shareholder empowerment platform administered by Investrend Communications, Inc., a provider of financial intelligence programs.

Institutional research coverage will be initiated by an Investrend Research analyst to be assigned in the next few days. Investrend Research is located on the web at http://www.investrendresearch.com, and the analysts' qualifications are at http://www.investrend.com/articles/secondlevel.asp?level=238.

American Oriental Bioengineering uses proprietary processes for producing soybean soybean, soya bean, or soy pea, leguminous plant (Glycine max, G. soja, or Soja max) of the family Leguminosae (pulse family), native to tropical and warm temperate regions of Asia, where it has been  protein peptide more efficiently than traditional extracting techniques. These techniques are used to manufacture and formulate supplemental and medicinal products medicinal product,
n a substance administered to humans or animals through injection, application, oral ingestion, inhalation, and so forth, whose purpose is to ultimately restore health or eliminate disease in an individual.
. Soybean peptides are used widely in general food, health food products and medicines, among other applications.

The company also produces Cease-Enuresis Soft Gel, the only China State FDA-approved first-grade, plant-based prescription medicine that is specially formulated to help alleviate bed-wetting and incontinence incontinence

Inability to control excretion. Starting and stopping urination relies on normal function in pelvic and abdominal muscles, diaphragm, and control nerves. Babies' nervous systems are too immature for urinary control. Later incontinence may reflect disorders (e.g.
. The company is a leading producer of products in both the nutraceuticals and pharmaceuticals areas in China.

The company's website is at http://www.bioaobo.com.

An InvestorPower(TM) page has been created regarding the company at http://www.investrend.com/company/list.asp?sPathParam=yes.

Investrend Research has been the leading independent equity research publishing and distribution program since 1996, with over 75 qualified professional analysts posting more than 1,000 reports to date. Anyone may enroll a company in the Investrend platforms. Enrollment fees for the Institutional research platform are $35,490, which is being paid by the company. Analysts are paid in advance for their initial reports by Investrend Research to limit or eliminate pecuniary Monetary; relating to money; financial; consisting of money or that which can be valued in money.


pecuniary adj. relating to money, as in "pecuniary loss.
 interests, and no one associated with the program may own or trade in the equities of companies under coverage.

The company has also been enrolled in the shareholder-monitoring program by the Shareholders Research Alliance (http://www.shareholdersresearch.com), established to eliminate conflict and bias, and Investrend subscribes to the exacting "Standards for Independent Research Providers" at http://www.firstresearchconsortium.com

Anyone interested in receiving alerts regarding American Oriental research or webcasts should e-mail contact@investrend.com with "AOB" in the subject line, or click on http://www.investrend.com/contact.asp.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:American Oriental Bioengineering Institutional Coverage To Be Initiated By Investrend Research.
Publication:Business Wire
Geographic Code:9CHIN
Date:Jan 17, 2006
Words:356
Previous Article:Playhouse Disney Preschool Time Online(TM) Lets Kids Play and Learn with Their Favorite Disney Channel Characters; New Premium Service Brings...
Next Article:Transoft Legacy Liberator To Move MWS Wire's Critical Supply Chain Applications off Legacy HPe3000.
Topics:



Related Articles
Investrend Announces Investment Opinion on Paradigm Medical Industries, Inc.
Investrend Research Announces Investment Opinion: Eden Energy Benchmark Research Coverage to Be Initiated by Investrend Research.
American Oriental Bioengineering, Inc. Closes $60 Million Private Placement.
International Monetary Systems Re-enrolls For Investrend Research Institutional Coverage; Webcast Posted.
American Oriental Bioengineering Rated 'Buy/4,' Target Valuation $6 By Investrend Analyst Kipley Lytel, CFA.
American Oriental Bioengineering Reiterated 'Buy/4,' Target Valuation $6 By Investrend Analyst Kipley Lytel, CFA.
American Oriental Bioengineering Reiterated 'Buy/4,' Target Valuation $6 By Investrend Analyst Kipley Lytel, CFA.
American Oriental Bioengineering Inc. to Present at the ICR XChange Asia Institutional Investor Conference.
American Oriental Bioengineering 'Posts Very Encouraging Q3FY06 Results,' 'Buy/4' Rating Reiterated, Target Raised To $12, In 'Institutional'...
Investrend Research Analyst Piyali Chakravarty Initiates Coverage On Smartcool Systems.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles